PT920421E - Derivados de isoxazolina uteis como agentes antimicrobianos - Google Patents

Derivados de isoxazolina uteis como agentes antimicrobianos

Info

Publication number
PT920421E
PT920421E PT97937156T PT97937156T PT920421E PT 920421 E PT920421 E PT 920421E PT 97937156 T PT97937156 T PT 97937156T PT 97937156 T PT97937156 T PT 97937156T PT 920421 E PT920421 E PT 920421E
Authority
PT
Portugal
Prior art keywords
uteis
antimicrobial agents
isoxazoline derivatives
isoxazoline
derivatives
Prior art date
Application number
PT97937156T
Other languages
English (en)
Portuguese (pt)
Inventor
Richard C Thomas
Michael R Barbachyn
Gary J Cleek
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PT920421E publication Critical patent/PT920421E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT97937156T 1996-08-21 1997-08-15 Derivados de isoxazolina uteis como agentes antimicrobianos PT920421E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2428796P 1996-08-21 1996-08-21

Publications (1)

Publication Number Publication Date
PT920421E true PT920421E (pt) 2003-03-31

Family

ID=21819822

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97937156T PT920421E (pt) 1996-08-21 1997-08-15 Derivados de isoxazolina uteis como agentes antimicrobianos

Country Status (10)

Country Link
US (2) US5990136A (enExample)
EP (1) EP0920421B1 (enExample)
JP (1) JP2000516245A (enExample)
AT (1) ATE227277T1 (enExample)
AU (1) AU3973697A (enExample)
DE (1) DE69716925T2 (enExample)
DK (1) DK0920421T3 (enExample)
ES (1) ES2186916T3 (enExample)
PT (1) PT920421E (enExample)
WO (1) WO1998007708A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
US6255304B1 (en) 1997-05-30 2001-07-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
CA2288750A1 (en) 1997-05-30 1998-12-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
DE69902634T2 (de) * 1998-02-13 2003-04-24 Pharmacia & Upjohn Co., Kalamazoo Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
AU3180999A (en) * 1998-02-25 1999-09-15 Pharmacia & Upjohn Company Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
CN1311787A (zh) 1998-06-05 2001-09-05 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物
US6420349B1 (en) 1998-08-24 2002-07-16 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
TW572757B (en) * 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
GB9928568D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6465456B2 (en) 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
ATE319710T1 (de) 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
CN1247511C (zh) * 2000-12-26 2006-03-29 财团法人乙卯研究所 环庚三烯酚酮衍生物
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
JP2006516991A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりn−置換されたオキサゾリジノン誘導体
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
BRPI0513083A (pt) * 2004-08-06 2008-04-22 Pharmacia & Upjohn Co Llc oxazolidinonas contendo oxindóis como agentes antibacterianos
CN102731490A (zh) * 2004-09-10 2012-10-17 先正达有限公司 作为杀真菌剂的取代异*唑
KR101508862B1 (ko) * 2010-08-05 2015-04-07 조에티스 엘엘씨 구충제로서 이속사졸린 유도체
CN103649079B (zh) 2010-12-22 2016-11-16 Abbvie公司 丙型肝炎抑制剂及其用途
WO2014055352A1 (en) * 2012-10-03 2014-04-10 Shell Oil Company Optimizing performance of a drilling assembly
WO2021000297A1 (en) 2019-07-03 2021-01-07 Merck Sharp & Dohme Corp. Compounds and methods of use thereof as antibacterial agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137326C (enExample) * 1967-08-26
US4283403A (en) * 1976-06-14 1981-08-11 Eli Lilly And Company Substituted isoxazolines for control of plant phytopathogens
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
PL175782B1 (pl) * 1992-12-08 1999-02-26 Upjohn Co Nowe podstawione troponem pochodne fenylooksazolidynonowe
JP2818820B2 (ja) * 1993-11-26 1998-10-30 ファイザー・インク. 抗炎症剤としての3−アリール−2−イソオキサゾリン類
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
US5710159A (en) * 1996-05-09 1998-01-20 The Dupont Merck Pharmaceutical Company Integrin receptor antagonists

Also Published As

Publication number Publication date
JP2000516245A (ja) 2000-12-05
WO1998007708A1 (en) 1998-02-26
AU3973697A (en) 1998-03-06
ES2186916T3 (es) 2003-05-16
EP0920421B1 (en) 2002-11-06
DE69716925T2 (de) 2003-09-11
US5990136A (en) 1999-11-23
ATE227277T1 (de) 2002-11-15
US6093736A (en) 2000-07-25
DK0920421T3 (da) 2003-03-10
DE69716925D1 (de) 2002-12-12
EP0920421A1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
PT920421E (pt) Derivados de isoxazolina uteis como agentes antimicrobianos
ATE293609T1 (de) Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
UY26551A1 (es) " agentes antibacterianos de 3-aminoquinazolin-2,4,dionas".
DE60118885D1 (de) Nitratsalze von antimikrobiellen wirkstoffen
PT942904E (pt) Derivados de 3-tiocarbamoilpirazol como pesticidas
PT1028961E (pt) Derivados de pleuromutilina como agentes antimicrobianos
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
PT1453512E (pt) Derivados de acetileno tendo actividade antagonistica do mglur 5
DE69636791D1 (de) Derivate von glykopeptidantibiotika
DE60131138D1 (de) Antibakterielle mittel
ES2243579T3 (es) Derivados de pirazolopirideno.
ES2195397T3 (es) Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos.
BR0014775B1 (pt) misturas antimicrobianas de 1,3-bis (hidroximetil) -5,5-dimetilidantoina e 1,2-benzisotiazolin-3-ona.
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
UA83266C2 (en) Oxazole derivatives of tetracyclines
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
DE69936052D1 (de) N1 modifizierte glycopeptide
PT1268475E (pt) Novos agentes bacterianos de benzosultam-oxazolidinona
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
NO982879L (no) Vannlöselige antibiotika
BRPI0411537A (pt) derivados de lincomicina que possuem atividade antibacteriana
PT1140932E (pt) Derivados de 1,8-benzonaftiridina